Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/16096
Title: Association of MTHFR C677T Genotype With Ischemic Stroke Is Confined to Cerebral Small Vessel Disease Subtype
Austin Authors: Rutten-Jacobs, Loes C A;Traylor, Matthew;Adib-Samii, Poneh;Thijs, Vincent;Sudlow, Cathie;Rothwell, Peter M;Boncoraglio, Giorgio;Dichgans, Martin;Meschia, James;Maguire, Jane;Levi, Christopher R;Rost, Natalia S;Rosand, Jonathan;Hassan, Ahamad;Bevan, Steve;Markus, Hugh S
Affiliation: Austin Health, Heidelberg, Victoria, Australia
Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK
Department of Medical and Molecular Genetics, King's College London, London, UK
Stroke and Dementia Research Centre, Department of Clinical Neuroscience, St George's University of London, London, UK
KULeuven Department of Experimental Neurology and Leuven Research Institute for Neuroscience and Disease, University of Leuven, and Laboratory of Neurobiology, Vesalius Research Center, VIB, Leuven, Belgium
Department of Neurology, Austin Health, Heidelberg, Victoria, Australia
Florey Institute of Neuroscience and Mental Health, Heidelberg, Victoria, Australia
Division of Clinical Neurosciences, Neuroimaging Sciences, University of Edinburgh, Edinburgh, UK
Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, UK
Stroke Prevention Research Unit, Nuffield Department of Neuroscience, University of Oxford, UK
Department of Cerebrovascular Diseases, Fondazione IRCCS Istituto Neurologico "Carlo Besta", Milano, Italy
Institute for Stroke and Dementia Research, Klinikum der Universität München, Ludwig-Maximilians-University Munich and Munich Cluster of Systems Neurology, SyNergy, Munich, Germany
Department of Neurology, Mayo Clinic, Jacksonville, Florida, USA
School of Nursing and Midwifery, University of Newcastle, Newcastle, NSW, Australia
Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia
Center for Human Genetic Research and Department of Neurology, Massachusetts General Hospital, Boston, Massachusetts, USA
Department of Neurology, Leeds General Infirmary, Leeds Teaching Hospitals NHS Trust, Leeds, UK
School of Life Science, University of Lincoln, Lincoln, UK
Issue Date: Mar-2016
metadata.dc.date: 2016-02-02
Publication information: Stroke 2016; 47(3):646-651
Abstract: BACKGROUND AND PURPOSE: Elevated plasma homocysteine levels are associated with stroke. However, this might be a reflection of bias or confounding because trials have failed to demonstrate an effect from homocysteine lowering in stroke patients, although a possible benefit has been suggested in lacunar stroke. Genetic studies could potentially overcome these issues because genetic variants are inherited randomly and are fixed at conception. Therefore, we tested the homocysteine levels-associated genetic variant MTHFR C677T for association with magnetic resonance imaging-confirmed lacunar stroke and compared this with associations with large artery and cardioembolic stroke subtypes. METHODS: We included 1359 magnetic resonance imaging-confirmed lacunar stroke cases, 1824 large artery stroke cases, 1970 cardioembolic stroke cases, and 14 448 controls, all of European ancestry. Furthermore, we studied 3670 ischemic stroke patients in whom white matter hyperintensities volume was measured. We tested MTHFR C677T for association with stroke subtypes and white matter hyperintensities volume. Because of the established association of homocysteine with hypertension, we additionally stratified for hypertension status. RESULTS: MTHFR C677T was associated with lacunar stroke (P=0.0003) and white matter hyperintensity volume (P=0.04), but not with the other stroke subtypes. Stratifying the lacunar stroke cases for hypertension status confirmed this association in hypertensive individuals (P=0.0002), but not in normotensive individuals (P=0.30). CONCLUSIONS: MTHFR C677T was associated with magnetic resonance imaging-confirmed lacunar stroke, but not large artery or cardioembolic stroke. The association may act through increased susceptibility to, or interaction with, high blood pressure. This heterogeneity of association might explain the lack of effect of lowering homocysteine in secondary prevention trials which included all strokes.
URI: http://ahro.austin.org.au/austinjspui/handle/1/16096
DOI: 10.1161/STROKEAHA.115.011545
PubMed URL: https://pubmed.ncbi.nlm.nih.gov/26839351
Type: Journal Article
Subjects: MTHFR
Cerebral small vessel disease
Gentic Association
Homocysteine
Lacunar Stroke
Appears in Collections:Journal articles

Show full item record

Page view(s)

12
checked on Dec 7, 2022

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.